This site is intended for healthcare professionals

Go to /sign-in page

You can view 5 more pages before signing in

Cholesterol emboli syndrome

Last reviewed dd mmm yyyy. Last edited dd mmm yyyy

Authoring team

The cholesterol emboli syndrome is a multi-system disease which may complicate:

  • arteriography
  • thrombolysis
  • anticoagulation
  • vascular surgery

The characteristic clinical triad is:

  • livedo reticularis
  • renal failure
  • eosinophilia

Multiple treatment regimens have been generally unsuccessful in altering the course of the disease process. The most significant impact on the disease can be made by its prevention

  • thrombolytic and anticoagulant treatments are not indicated and only supportive care for such symptoms as hypertension, ulceration, and gangrene is advocated
  • prognosis depends on the extent of the systemic disease and a high rate of mortality (75–80%) is recorded due to multifactorial, cardiac, and renal aetiologies
  • prognosis is poor with high mortality and the treatment is only supportive

Reference:


Related pages

Create an account to add page annotations

Add information to this page that would be handy to have on hand during a consultation, such as a web address or phone number. This information will always be displayed when you visit this page